An RCT study by Chang et al. [80] in Korean patients with IBD demonstrated a significant reduction in thiopurine-induced myelosuppression and leukopenia in several genotype groups where patients carrying NUDT15 variants received a lower initial dose or alternative therapy. Here, NUDT15 is linked to inflammatory bowel disease.